MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 21.02.2026
I-Mab PEG 2011-2026 | IMAB
PEG Jährlich I-Mab
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.75 | 0.351 | - | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.351 | -0.75 | -0.199 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ADMA Biologics
ADMA
|
0.937 | $ 16.64 | 1.59 % | $ 3.97 B |  USA |
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Apellis Pharmaceuticals
APLS
|
-5.4 | $ 19.84 | -1.59 % | $ 2.5 B | USA |
 |
Aptorum Group Limited
APM
|
0.0951 | $ 0.82 | 3.59 % | $ 4.47 M |  China |
 |
Graybug Vision
GRAY
|
0.122 | - | -11.23 % | $ 9.65 M | USA |
 |
Axsome Therapeutics
AXSM
|
-5.2 | $ 164.97 | 0.56 % | $ 8.21 B | USA |
 |
AbCellera Biologics
ABCL
|
0.0142 | $ 3.67 | -1.21 % | $ 1.1 B |  Canada |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | USA |
 |
BioLineRx Ltd.
BLRX
|
1.32 | $ 2.84 | 1.07 % | $ 908 M |  Israel |
 |
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | USA |
 |
BioMarin Pharmaceutical
BMRN
|
0.177 | $ 60.49 | 3.35 % | $ 11.6 B | USA |
 |
Athersys
ATHX
|
0.0584 | - | 3.77 % | $ 22.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
-0.00128 | - | - | $ 521 M | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | USA |
 |
Burford Capital Limited
BUR
|
-0.568 | $ 8.41 | -1.64 % | $ 1.39 B | Britain |
 |
Cabaletta Bio
CABA
|
-0.00014 | $ 3.39 | 4.35 % | $ 3.96 M | USA |
 |
BridgeBio Pharma
BBIO
|
0.28 | $ 65.92 | 2.15 % | $ 12.6 B | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
0.0439 | - | - | $ 789 M | USA |
 |
Codexis
CDXS
|
-0.0807 | $ 1.06 | 8.16 % | $ 77.8 M | USA |
 |
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | USA |
 |
Clovis Oncology
CLVS
|
0.0458 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | USA |
 |
Coherus BioSciences
CHRS
|
0.0108 | $ 1.79 | 8.18 % | $ 169 M | USA |
 |
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
4.94 | - | - | $ 1.2 B | USA |
 |
CohBar
CWBR
|
-0.00119 | - | -15.44 % | $ 2.2 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.0018 | - | -5.98 % | $ 34.1 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
1.4 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Capricor Therapeutics
CAPR
|
0.317 | $ 26.23 | 1.49 % | $ 702 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | Canada |
 |
Champions Oncology
CSBR
|
-0.211 | $ 6.1 | 1.67 % | $ 83.3 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Citius Pharmaceuticals
CTXR
|
-0.00125 | $ 0.81 | 9.12 % | $ 5.45 M | USA |